Heparin Sodium Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Heparin Sodium Injection (injection) from Baxter Healthcare with status Current. The shortage was first posted on Nov 14, 2017. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Baxter Healthcare
- Package NDC
- 0338-0431-03
- Dosage Form
- Injection
- Presentation
- Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03)
- Initial Posting
- Nov 14, 2017
Reason
Demand increase for the drug